ZDHHC5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.251400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.975600E-01
Normal-vs-Stage2
1.702220E-01
Normal-vs-Stage3
8.956400E-01
Normal-vs-Stage4
5.494400E-02
Stage1-vs-Stage2
4.039000E-01
Stage1-vs-Stage3
6.053400E-01
Stage1-vs-Stage4
1.663630E-01
Stage2-vs-Stage3
1.770990E-01
Stage2-vs-Stage4
4.270200E-01
Stage3-vs-Stage4
1.836600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.679000E-01
Normal-vs-AfricanAmerican
1.090600E-01
Normal-vs-Asian
1.080650E-01
Caucasian-vs-AfricanAmerican
4.104400E-01
Caucasian-vs-Asian
1.101550E-01
AfricanAmerican-vs-Asian
7.579600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.448000E-01
Normal-vs-Female
2.091000E-01
Male-vs-Female
7.685800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.122800E-01
Normal-vs-Age(41-60Yrs)
6.440100E-02
Normal-vs-Age(61-80Yrs)
3.423600E-01
Normal-vs-Age(81-100Yrs)
2.661200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.241800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.197000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.165600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.944470E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.631360E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.949400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.364800E-01
Normal-vs-Daily Drinker
4.470000E-01
Normal-vs-Weekly Drinker
2.712400E-01
Normal-vs-Occasional Drinker
8.494000E-02
Normal-vs-Social Drinker
1.196420E-01
Non Drinker-vs-Daily Drinker
9.194600E-01
Non Drinker-vs-Weekly Drinker
6.426400E-01
Non Drinker-vs-Occasional Drinker
6.088100E-02
Non Drinker-vs-Social Drinker
3.962800E-01
Daily Drinker-vs-Weekly Drinker
7.365200E-01
Daily Drinker-vs-Occasional Drinker
1.074360E-01
Daily Drinker-vs-Social Drinker
4.947400E-01
Weekly Drinker-vs-Occasional Drinker
2.129200E-01
Weekly Drinker-vs-Social Drinker
7.343000E-01
Occasional Drinker-vs-Social Drinker
2.963600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.302800E-01
Normal-vs-Grade 2
1.558380E-02
Normal-vs-Grade 3
6.660200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.201100E-03
Grade 1-vs-Grade 3
3.443300E-04
Grade 1-vs-Grade 4
2.302800E-01
Grade 2-vs-Grade 3
1.900760E-01
Grade 2-vs-Grade 4
1.558380E-02
Grade 3-vs-Grade 4
6.660200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.715400E-01
Normal-vs-NonDiabetic
1.795420E-01
Diabetic-vs-NonDiabetic
1.365620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.579400E-03
Normal-vs-NoPancreatitis
2.910600E-01
Pancreatitis-vs-NoPancreatitis
5.756800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.182400E-01
Normal-vs-N1
2.046800E-01
N0-vs-N1
6.358000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.782900E-03
Normal-vs-TP53-NonMutant
6.182800E-01
TP53-Mutant-vs-TP53-NonMutant
9.8714000307254E-09
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
